© 2018 Miraculo Inc. All Rights Reserved
Video Credit: CBD-Healthcare
Dr. Cristina Sánchez is a Spanish molecular biologist at Complutense University. She went on to study the antitumoral and other properties of medical cannabis in cancer and the therapeutic qualities of cannabinoids resulting in her discovery of the anti-cancer properties of THC.
Her inspiration has come from Raffi McCollum, a professor from the Hebrew University in characterized the main compound in marijuana, producing the psychoactive effects that we all know the cannabis.
Cristina explains that the we now know that the endocannabinoid system regulates a lot of biological function such as:
In Cristina’s lab, they noticed that THC, the main psychoactive component of cannabis proved to kill cells, so she decided to test this analysis on animal models on breast and brain tumours. Cristina says
“The results we have obtained are telling us that cannabinoids may be useful for the treatment of breast cancer. It’s reducing tumor growth. Cells can die in different ways and after cannabinoid treatment, they were dying in the clean way, they were committing suicide”.
Through her studies, she noticed that cannabinoids don’t have any toxic effect on healthy cells and only target specific cells.
She can not understand why cannabis, is under the schedule 1 list of drugs.
Schedule I drugs are those that have the following characteristic:
At this point, Cristina has enough pre-clinical evidence supporting the idea that cannabinoids may have anti-tumor properties. It’s important to understand the functions of cannabis and it’s medical properties, however, if you wish to use medical cannabis as a form of treatment, make sure you talk to a medical professional.